News
As Eli Lilly and Novo Nordisk continue to go in opposite directions in their diabetes and obesity market rivalry, so too have they changed positions in the annual IDEA Pharma Innovation Index, which ...
Major pharmaceutical manufacturing company Eli Lilly is considering a $5.7 billion investment into a facility in Houston.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback